Bing

SEARCH HISTORY

Stocks of Cytori Therapeutics, Inc. (NASDAQ:CYTX) closed at $0.52 in last session with the total traded volume of 1.65 Million. The Financial Institutional ownership of the firm was 27.10% while by insiders was 0.70%. Zogenix, Inc. (NASDAQ:ZGNX ...
emarketsdaily.com · 1/13/2015
One stock that might be an intriguing choice for investors right now is Zogenix, Inc. ( ZGNX). This is because this security in the Medical Drug space is seeing solid earnings estimate revision activity, and is in great company from a Zacks Industry Rank ...
NASDAQ · 5/1/2014
A year ago, they were trading at $2.29. This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on ZGNX at http://www.zacks.com/ap/ZGNX
CNBC · 5/11/2015
More from Bing News
Zogenix, Inc. (ZGNX) of the Healthcare sector is up 0.00% (change from open -1.28%) this morning trading at a volume of 201,608 shares and price of $1.54. Zogenix, Inc. (ZGNX)’s weekly performance is 7.69% and compared to their 52 week low, they are …
wallstreetscope.com · 2/25/2015
Both Zogenix, Inc. (NASDAQ:ZGNX) and Derma Sciences Inc (NASDAQ:DSCI) are microcaps with market capitalizations of $204.72 million and $205.87 million respectively. The most popular stock picks of hedge funds, on the other hand are all large cap …
INSIDER MONKEY · 3/19/2015
Zogenix, Inc. had 1st quarter 2014 revenues of $7.7M USD. This missed the $8.7M USD consensus estimate of the 4 analysts following the company. This was 9.9% above the prior year's 1st quarter results.
Bloomberg · 5/11/2015
(click to enlarge) Recently, I have notice two of my Shotgun Investing stocks that are both going for just under ... Let's start with Zogenix (NASDAQ:ZGNX). This small biopharma was primarily focused on developing therapies that address specific clinical ...
Seeking Alpha · ByBret Jensen · 4/16/2015
Zogenix Inc. (NASDAQ: ZGNX) announced an agreement for the sale of its Zohydro ER (hydrocodone bitartrate) business to Pernix for $100 million. This transaction will be composed of $30 million in cash, $20 million in Pernix common stock and a $50 …
24/7 Wall ST · 3/11/2015
Zogenix Inc. (NASDAQ: ZGNX) is down 5 percent after-hours Wednesday after it entered into a Controlled Equity OfferingSM Sales Agreement with Cantor Fitzgerald & Co., as sales agent, under which the Company may, from time to time, sell shares of its …
StreetInsider · 3/27/2013
Zogenix, Inc. (ZGNX) in Focus: Stock Jumps 8.1% - Tale of the Tape (Zacks) Although it received FDA approval in 2013, Zogenix, Inc. (NASDAQ: ZGNX) had a lackluster 2014. The stock fell about 70 percent on the year, as investors exited due to political ...
Benzinga · 1/26/2015